- Home
- CWK vs BHVN Comparison
CWK vs BHVN Comparison
Compare CWK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWK
- BHVN
- Stock Information
- Founded
- CWK 1784
- BHVN 2013
- Country
- CWK United States
- BHVN United States
- Employees
- CWK N/A
- BHVN N/A
- Industry
- CWK Real Estate
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CWK Finance
- BHVN Health Care
- Exchange
- CWK Nasdaq
- BHVN Nasdaq
- Market Cap
- CWK 1.9B
- BHVN 1.9B
- IPO Year
- CWK 2018
- BHVN 2017
- Fundamental
- Price
- CWK $10.26
- BHVN $20.24
- Analyst Decision
- CWK Hold
- BHVN Strong Buy
- Analyst Count
- CWK 7
- BHVN 14
- Target Price
- CWK $12.93
- BHVN $62.92
- AVG Volume (30 Days)
- CWK 2.9M
- BHVN 2.2M
- Earning Date
- CWK 04-29-2025
- BHVN 05-16-2025
- Dividend Yield
- CWK N/A
- BHVN N/A
- EPS Growth
- CWK 1337.16
- BHVN N/A
- EPS
- CWK 0.69
- BHVN N/A
- Revenue
- CWK $9,546,300,000.00
- BHVN N/A
- Revenue This Year
- CWK $5.32
- BHVN N/A
- Revenue Next Year
- CWK $5.06
- BHVN $65.26
- P/E Ratio
- CWK $14.78
- BHVN N/A
- Revenue Growth
- CWK 1.24
- BHVN N/A
- 52 Week Low
- CWK $7.64
- BHVN $15.79
- 52 Week High
- CWK $16.11
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CWK 62.02
- BHVN 43.79
- Support Level
- CWK $9.80
- BHVN $18.75
- Resistance Level
- CWK $10.19
- BHVN $24.06
- Average True Range (ATR)
- CWK 0.33
- BHVN 2.00
- MACD
- CWK 0.24
- BHVN 0.21
- Stochastic Oscillator
- CWK 94.44
- BHVN 42.39
About CWK Cushman & Wakefield plc
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.